(Q37862783)

24 August 2017

1 reference

title

Antibodies in infectious diseases: polyclonals, monoclonals and niche biotechnology (English)

1 reference

24 August 2017

0 references

1 reference

Jody D Berry

1

1 reference

24 August 2017

Ryan G Gaudet

series ordinal

2

1 reference

24 August 2017

publication date

5 April 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

28

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

489-501

1 reference

Synergy between acylureidopenicillins and immunoglobulin G in experimental animals

24 August 2017

cites work

1 reference

12 December 2020

Prophylaxis and therapy for Chikungunya virus infection

1 reference

12 December 2020

Antigen-specific human polyclonal antibodies from hyperimmunized cattle.

1 reference

12 December 2020

Mining human antibody repertoires

1 reference

12 December 2020

Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody

1 reference

12 December 2020

An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo

1 reference

12 December 2020

Bispecific monoclonal antibody complexes facilitate erythrocyte binding and liver clearance of a prototype particulate pathogen in a monkey model

1 reference

12 December 2020

Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology

1 reference

12 December 2020

HIV vaccine design and the neutralizing antibody problem

1 reference

12 December 2020

Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection

1 reference

12 December 2020

Mechanism for the isotype dependence of antibody-mediated toxicity in Cryptococcus neoformans-infected mice

1 reference

12 December 2020

Effect of a human IgG preparation rich in antibodies to a wide range of lipopolysaccharides on gram-negative bacterial sepsis in burned mice

1 reference

12 December 2020

Biological role of different antibody classes

1 reference

12 December 2020

A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities.

1 reference

12 December 2020

Glycosylation of recombinant antibody therapeutics

1 reference

12 December 2020

The growth and potential of human antiviral monoclonal antibody therapeutics.

1 reference

12 December 2020

Effect of Gm allotypes on IgG2 antibody responses and IgG2 concentrations in children and adults

1 reference

12 December 2020

Mode of interaction between immunoglobulin G and mezlocillin against beta-lactamase producing bacteria

1 reference

12 December 2020

Instant immunity through chemically programmable vaccination and covalent self-assembly

1 reference

12 December 2020

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

1 reference

12 December 2020

Pseudomonas hyperimmune globulin passive immunotherapy for pulmonary exacerbations in cystic fibrosis

1 reference

12 December 2020

Combination therapy using chimeric monoclonal antibodies protects mice from lethal H5N1 infection and prevents formation of escape mutants.

1 reference

12 December 2020

Breaking the one antibody-one target axiom

1 reference

12 December 2020

Isotype selection in antibody engineering

1 reference

12 December 2020

Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection

1 reference

12 December 2020

Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils

1 reference

12 December 2020

Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus

1 reference

12 December 2020

High level expression of functional human IgMs in human PER.C6 cells

1 reference

12 December 2020

Targeting of Pseudomonas aeruginosa in the bloodstream with bispecific monoclonal antibodies.

1 reference

12 December 2020

Vaccines: countering anthrax: vaccines and immunoglobulins

1 reference

12 December 2020

Anti-Clumping Factor A Immunoglobulin Reduces the Duration of Methicillin-ResistantStaphylococcus aureusBacteremia in an Experimental Model of Infective Endocarditis

1 reference

12 December 2020

Locally delivered antibodies combined with systemic antibiotics confer synergistic protection against antibiotic-resistant burn wound infection

1 reference

12 December 2020

Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin

1 reference

12 December 2020

Antibody cocktails: next-generation biopharmaceuticals with improved potency

1 reference

12 December 2020

On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes

1 reference

12 December 2020

Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine

1 reference

12 December 2020

Efficient serum clearance of botulinum neurotoxin achieved using a pool of small antitoxin binding agents

1 reference

12 December 2020

Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection

1 reference

12 December 2020

[Therapeutic antibodies and related products: choosing the right structure for success]

1 reference

12 December 2020

Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV.

1 reference

12 December 2020

Antibacterial properties of Pseudomonas aeruginosa immunotype 1 lipopolysaccharide-specific monoclonal antibody (MAb) in a murine thigh infection model: combined effects of MAb and ceftazidime

1 reference

12 December 2020

Characterization of a novel protective monoclonal antibody that recognizes an epitope common to Vibrio cholerae Ogawa and Inaba serotypes

1 reference

12 December 2020

Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses

1 reference

12 December 2020

A meta-analysis of the effect of antibody therapy for the prevention of severe respiratory syncytial virus infection

1 reference

12 December 2020

Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model

1 reference

12 December 2020

Single-batch production of recombinant human polyclonal antibodies

1 reference

12 December 2020

Functional antibodies targeting IsaA of Staphylococcus aureus augment host immune response and open new perspectives for antibacterial therapy

1 reference

12 December 2020

Infection control by antibody disruption of bacterial quorum sensing signaling

1 reference

12 December 2020

A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis

1 reference

12 December 2020

Monoclonal antibodies inhibit prion replication and delay the development of prion disease

1 reference

12 December 2020

Feasibility of radioimmunotherapy of experimental pneumococcal infection

1 reference

12 December 2020

The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1

1 reference

12 December 2020

Monoclonal immunoglobulin G1 directed against Aspergillus fumigatus cell wall glycoprotein protects against experimental murine aspergillosis

1 reference

12 December 2020

Antiretroviral-drug resistance among patients recently infected with HIV.

1 reference

12 December 2020

Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia

1 reference

12 December 2020

Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants

1 reference

12 December 2020

Prevention of infection in multiple trauma patients by high-dose intravenous immunoglobulins

1 reference

12 December 2020

Antibody therapeutics: isotype and glycoform selection

1 reference

12 December 2020

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

1 reference

12 December 2020

A new product (VariZIG) for postexposure prophylaxis of varicella available under an investigational new drug application expanded access protocol.

1 reference

12 December 2020

Monoclonal antibody-based therapies for microbial diseases

1 reference

12 December 2020

Clearance of prions during plasma protein manufacture.

1 reference

12 December 2020

Oropharyngeal aspiration of ricin as a lung challenge model for evaluation of the therapeutic index of antibodies against ricin A-chain for post-exposure treatment.

1 reference

12 December 2020

Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia

1 reference

12 December 2020

Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-L

1 reference

12 December 2020

Engineered antibody Fc variants with enhanced effector function

1 reference

12 December 2020

Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants

1 reference

12 December 2020

A single-use purification process for the production of a monoclonal antibody produced in a PER.C6 human cell line

1 reference

12 December 2020

Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms

1 reference

12 December 2020

Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A.

1 reference

12 December 2020

Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge

1 reference

12 December 2020

Raxibacumab for the treatment of inhalational anthrax

1 reference

12 December 2020

In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody

1 reference

12 December 2020

Passive protection of purified yolk immunoglobulin administered against Shiga toxin 1 in mouse models

1 reference

12 December 2020

Susceptibility of the human pathogenic fungi Cryptococcus neoformans and Histoplasma capsulatum to gamma-radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes.

1 reference

12 December 2020

Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway

1 reference

12 December 2020

Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2.

1 reference

12 December 2020

Epitopes involved in antibody-mediated protection from Ebola virus

1 reference

12 December 2020

Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing

1 reference

12 December 2020

Antibiotic use in relation to the risk of breast cancer

1 reference

12 December 2020

Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein

1 reference

12 December 2020

Immunoprophylaxis of RSV infection: advancing from RSV-IGIV to palivizumab and motavizumab

1 reference

12 December 2020

Progress towards recombinant anti-infective antibodies

1 reference

12 December 2020

Human anti-plague monoclonal antibodies protect mice from Yersinia pestis in a bubonic plague model

1 reference

12 December 2020

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

1 reference

12 December 2020

Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems.

1 reference

12 December 2020

Recombinant human polyclonal antibodies: A new class of therapeutic antibodies against viral infections.

1 reference

12 December 2020

Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy

1 reference

12 December 2020

Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function

1 reference

12 December 2020

Treatment with monoclonal antibodies against Clostridium difficile toxins

1 reference

12 December 2020

Serum IgG mediates mucosal immunity against rotavirus infection

1 reference

12 December 2020

Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax

1 reference

12 December 2020

Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients

1 reference

12 December 2020

Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency

1 reference

12 December 2020

Potent antiviral synergy between monoclonal antibody and small-molecule CCR5 inhibitors of human immunodeficiency virus type 1

1 reference

12 December 2020

Veronate (Inhibitex).

1 reference

12 December 2020

Investigational heptavalent botulinum antitoxin (HBAT) to replace licensed botulinum antitoxin AB and investigational botulinum antitoxin E

1 reference

12 December 2020

A model for neutralization of viruses based on antibody coating of the virion surface

1 reference

12 December 2020

Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity

1 reference

12 December 2020

Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity

1 reference

12 December 2020

Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge

1 reference

12 December 2020

Characterization of HIV-1 neutralization escape mutants

1 reference

12 December 2020

Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases

1 reference

12 December 2020

Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3

1 reference

12 December 2020

Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection.

1 reference

12 December 2020

Return to the Past: The Case for Antibody-Based Therapies in Infectious Diseases

1 reference

12 December 2020

Fusion of influenza virus with the endosomal membrane is inhibited by monoclonal antibodies to defined epitopes on the hemagglutinin.

1 reference

12 December 2020

A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge

1 reference

12 December 2020

Increased risk of childhood asthma from antibiotic use in early life

1 reference

12 December 2020

Preclinical in vitro and in vivo characterization of the fully human monoclonal IgM antibody KBPA101 specific for Pseudomonas aeruginosa serotype IATS-O11.

1 reference

12 December 2020

Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers

1 reference

12 December 2020

Potential of anti-Candida antibodies in immunoprophylaxis.

1 reference

12 December 2020

Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease

1 reference

12 December 2020

Intranasal delivery of an IgA monoclonal antibody effective against sublethal H5N1 influenza virus infection in mice

1 reference

12 December 2020

Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge

1 reference

12 December 2020

Locally delivered polyclonal antibodies potentiate intravenous antibiotic efficacy against gram-negative infections

1 reference

12 December 2020

Cost effectiveness of respiratory syncytial virus prophylaxis: a critical and systematic review

1 reference

12 December 2020

Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism

1 reference

12 December 2020

An engineered human antibody fab fragment specific for Pseudomonas aeruginosa PcrV antigen has potent antibacterial activity

1 reference

12 December 2020

The monoclonal antibody against the major diagnostic antigen of Paracoccidioides brasiliensis mediates immune protection in infected BALB/c mice challenged intratracheally with the fungus.

1 reference

12 December 2020

Monoclonal antibodies for prophylaxis and therapy of infectious diseases

1 reference

12 December 2020

Rational monoclonal antibody development to emerging pathogens, biothreat agents and agents of foreign animal disease: The antigen scale

1 reference

12 December 2020

A camelid anti-PrP antibody abrogates PrP replication in prion-permissive neuroblastoma cell lines

1 reference

12 December 2020

Glycosylation as a strategy to improve antibody-based therapeutics

1 reference

12 December 2020

Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques

1 reference

12 December 2020

Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against influenza A M2 protein

1 reference

12 December 2020

Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus

1 reference

12 December 2020

A novel glyco-conjugate vaccine against fungal pathogens

1 reference

12 December 2020

10.1016/J.NBT.2011.03.018

Identifiers

DOI

1 reference

24 August 2017

1 reference